DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sprx-105 is a drug marketed by Numark and is included in one NDA.
The generic ingredient in SPRX-105 is phendimetrazine tartrate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
A generic version of SPRX-105 was approved as phendimetrazine tartrate by VIRTUS PHARMS on December 31st, 1969.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Numark||SPRX-105||phendimetrazine tartrate||CAPSULE, EXTENDED RELEASE;ORAL||088024-001||Dec 22, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|